Why Choose Us
Top-Rated Care for Pediatric Cancer and Blood Disorders
Dana-Farber/Boston Children's Cancer and Blood Disorders Center offers the combined expertise of both a world class cancer center and an internationally renowned children’s hospital. Neighboring institutes connected by pedestrian bridges, Dana-Farber Cancer Institute and Boston Children's Hospital work together to offer seamless, integrated care for children with all types of cancer and blood disorders — including the rarest and most complex cases. Through our joint partnership, Dana-Farber/Boston Children's offers more specialists, more treatment options, and more clinical trials than almost any other pediatric center treating cancer and blood disorders in the world.
Our Expertise in Treating Pediatric Cancer and Blood Disorders
Our hematologists and oncologists are among the world leaders in their respective specialties; many have pioneered treatments that have been adopted by medical communities around the globe.
Read about our doctors and other clinicians who serve as your primary team throughout treatment.
Our doctors also collaborate with teams of expert subspecialists to provide truly comprehensive care for our patients. Dana-Farber/Boston Children's is the only pediatric cancer and blood disorders center in the country that integrates the specialized resources of a top pediatric hospital — Boston Children's Hospital — with those of a world renowned cancer center — Dana-Farber Cancer Institute. No other center of its kind can offer your child our breadth of expertise.
Learn more
- Innovative approaches: We offer a range of innovative approaches to the treatment of pediatric cancer and blood disorders.
- Survivorship: Caring for children with cancer and blood disorders doesn’t end after treatment. Our survivorship programs are the nation’s models for cancer survivorship care.
- Our leadership: Our leadership team members are internationally recognized researchers and physicians.
- History and milestones: Dana-Farber/Boston Children's has a long history as a world leader in the research and treatment of cancer and blood disorders.